Literature DB >> 2942386

Antiviral drugs for AIDS. Current status and future prospects.

E Sandström.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2942386     DOI： 10.2165/00003495-198631060-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  21 in total

1.  The broad spectrum antiviral agent ribavirin inhibits capping of mRNA.

Authors:  B B Goswami; E Borek; O K Sharma; J Fujitaki; R A Smith
Journal:  Biochem Biophys Res Commun       Date:  1979-08-13       Impact factor: 3.575

Review 2.  Suramin: with special reference to onchocerciasis.

Authors:  F Hawking
Journal:  Adv Pharmacol Chemother       Date:  1978

3.  Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome.

Authors:  W Rozenbaum; D Dormont; B Spire; E Vilmer; M Gentilini; C Griscelli; L Montagnier; F Barre-Sinoussi; J C Chermann
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

Review 4.  Specific targets for antiviral drugs.

Authors:  E De Clercq
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

5.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984

6.  Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses.

Authors:  E De Clercq
Journal:  Cancer Lett       Date:  1979-11       Impact factor: 8.679

7.  Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo.

Authors:  W M Shannon
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

8.  Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo.

Authors:  S Broder; R Yarchoan; J M Collins; H C Lane; P D Markham; R W Klecker; R R Redfield; H Mitsuya; D F Hoth; E Gelmann
Journal:  Lancet       Date:  1985-09-21       Impact factor: 79.321

9.  Longitudinal study of persistent generalised lymphadenopathy in homosexual men: relation to acquired immunodeficiency syndrome.

Authors:  U Mathur-Wagh; R W Enlow; I Spigland; R J Winchester; H S Sacks; E Rorat; S R Yancovitz; M J Klein; D C William; D Mildvan
Journal:  Lancet       Date:  1984-05-12       Impact factor: 79.321

10.  Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes.

Authors:  J B McCormick; J P Getchell; S W Mitchell; D R Hicks
Journal:  Lancet       Date:  1984-12-15       Impact factor: 79.321
View more
  2 in total

1.  Cyclosporine-induced deterioration in patients with AIDS.

Authors:  A Phillips; M A Wainberg; R Coates; M Klein; A Rachlis; S Read; F Shepherd; H Vellend; S Walmsley; P Halloran
Journal:  CMAJ       Date:  1989-06-15       Impact factor: 8.262

Review 2.  Vaccine and antiviral strategies against infections caused by human immunodeficiency virus.

Authors:  M A Wainberg; O Kendall; N Gilmore
Journal:  CMAJ       Date:  1988-05-01       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.